Company Filing History:
Years Active: 2014
Title: Xiaorong Pan: Innovator in Cancer Research
Introduction
Xiaorong Pan is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of cancer research, particularly through her innovative work on epidermal growth factor receptor variants.
Latest Patents
Xiaorong Pan holds a patent for "Epidermal growth factor receptor variants and pharmaceutical compositions thereof." This patent includes a novel Epidermal growth factor receptor variant, known as EGFRvA, along with a polynucleotide encoding the EGFRvA protein. The patent also describes a method for preparing the EGFRvA protein using recombination technology. Notably, the EGFRvA protein has been shown to promote tumor cell invasion and migration, highlighting its potential implications in cancer treatment.
Career Highlights
Xiaorong Pan is affiliated with the Shanghai Cancer Institute, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to understanding and combating cancer.
Collaborations
Xiaorong collaborates with esteemed colleagues, including Zonghai Li and Hai Feng Wang, to advance research in her field.
Conclusion
Xiaorong Pan's contributions to cancer research through her patent on epidermal growth factor receptor variants exemplify her dedication to innovation in medicine. Her work continues to inspire advancements in cancer treatment and research.